Algernon Pharmaceuticals Inc. have announced, via a press release, that they have appointed former NFL Nuerological Player Care Safety Director Dr. David Brody to their advisory board.
Algernon is currently developing methods of treating traumatic brain injuries (TBIs) with N,N-Dimethyltryptamine, a substance better known as DMT.
DMT is compound that appears naturally in many plants and animals. It is most known for its psychedelic properties and is a key ingredient in ayahuasca, which is used by many Indigenous people who live in and around the Amazon rain forest.
DMT offers similar effects to those provided by LSD and psilocybin mushrooms, with those who imbibe reporting hallucinations and intense feelings of euphoria.